We want to provide support for people in Monterey County who are on the journey of Parkinson’s disease, which is quite a ...
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) said it will begin enrolling patients in January 2026 in a large, long-term study designed to assess whether its experimental Parkinson’s disease ...
inews.co.uk on MSN
I reversed my Parkinson’s symptoms with daily doses of infrared light
A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...
Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.
A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...
He returns to being a head coach after several years as a college assistant ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
The Michael J. Fox Foundation for Parkinson’s Research, which the actor founded in 2000, has lobbied for a ban on ...
Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...
AC Immune (ACIU) added ~30% in the premarket on Thursday after the Swiss biotech announced positive initial results from a mid-stage trial for ACI-7104.056, an immunotherapy targeting early ...
Shares of Swiss drugmaker AC Immune rose by double-digits Thursday after the company reported positive data from a clinical trial testing its experimental vaccine for Parkinson’s disease. The vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback